Similarly, CCN1 decreases Cytarabine chemosensitivity in ALL cells via NF-κB pathway activation, and inhibition of CCN1 can restore ALL cell response to Cytarabine in vitro (Cao et al. 2019). Here, NFKB1 is linked to acute lymphoblastic leukemia.